Opportunity overview
Team Leidos are proud to be delivering the logistics commodities and services transformation (LCS(T)) Delivery partner contracts (LCS (T)/0001 dated 16.4.2015) on behalf of the UK Ministry of Defence (the ‘ Prime Contract’). Delivery of other parts of the LCS(T) contract are delivered by Leidos Europe Ltd (LEL) and other partners (together ‘Team Leidos’). This requirement is subject to the Public Procurement Regulations and respective advertising action
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
BHR Pharmaceuticals Ltd
- Contract value
- £600k
- Awarded
- Not supplied
- Contract signed
- 12 Jan 2026
- Award ID
- 010245-2026-LSL/MED/0209-1
- Status
- active
- Location
- Warwickshire,, UK, CV11 6GY, United Kingdom
Classification
- CPV33000000 — Medical equipments, pharmaceuticals and personal care products
Lots
- In April 2015 the MOD signed a thirteen year contract with Leidos Europe Ltd to provide the procurement and inventory management of commodity items (as well as the storage and distribution services) historically provided in-house by the Logistic Commodities and Services Operating Centre. Leidos, working with the MOD, will transform the way these services are delivered to ensure requirements continue to be met whilst providing best value for money for the department. The organisation delivering these services is known as Team Leidos. Team Leidos would like to make interested suppliers aware that it has awarded tenders for its supply and Support of Blood Glucose Monitor. Further to the VTN issued on 07/10/2025 reference LSL/MED/0209 - The Supply and Support of Blood Glucose Monitor FTS Notice Number 2025/S 000-062957 Notice Reference (2025-048652) https://www.find-tender.service.gov.uk/Notice/062957-2025 Leidos Supply Ltd has awarded the Supply and Support of Blood Glucose Monitor to BHR Pharmaceuticals Ltd on a 3 year term from 12/06/2026, with an estimated value of £600,000 across the 3 years.Value not stated